LONDON, ON and HERZLIYA, ISRAEL, Oct. 5, 2026 /CNW/ -- EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease ...
EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis framework beyond methylation microarrays to sequencing-derived DNA ...
StockStory.org on MSN
Why PacBio (PACB) stock is trading up today
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 9.9% in the afternoon ...
A new review explains how DNA methylation episignatures provide functional evidence of disease mechanism in rare genetic ...
DNA methylation is a critical epigenetic mechanism in numerous biological processes, including gene regulation, development, ageing and the onset of various diseases such as cancer. Studies of ...
In a recent study published in the journal Science Advances, researchers estimated the maximal longevity, gestation period, and sexual maturity age using deoxyribonucleic methylation (DNAm) by ...
DNA methylation is a key epigenome component that helps dictate how genes are expressed, contributing to normal cell and tissue differentiation during development, as well as the process of biological ...
In one of the most ambitious epigenomic studies yet attempted in livestock, researchers have assembled a vast multi-omics ...
Pacific Biosciences of California's business model struggles to gain traction versus larger, profitable competitors like Illumina. Read why PACB stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results